These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27527575)

  • 1. Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey.
    Deandrea S; Molina-Barceló A; Uluturk A; Moreno J; Neamtiu L; Peiró-Pérez R; Saz-Parkinson Z; Lopez-Alcalde J; Lerda D; Salas D
    Prev Med; 2016 Oct; 91():250-263. PubMed ID: 27527575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammographic screening programmes in Europe: organization, coverage and participation.
    Giordano L; von Karsa L; Tomatis M; Majek O; de Wolf C; Lancucki L; Hofvind S; Nyström L; Segnan N; Ponti A; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J J; Lancucki L; Ducarroz S; Suonio E
    J Med Screen; 2012; 19 Suppl 1():72-82. PubMed ID: 22972813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15.
    Walsh B; Silles M; O'Neill C
    Health Policy; 2011 Aug; 101(3):269-76. PubMed ID: 21420755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Basu P; Ponti A; Anttila A; Ronco G; Senore C; Vale DB; Segnan N; Tomatis M; Soerjomataram I; Primic Žakelj M; Dillner J; Elfström KM; Lönnberg S; Sankaranarayanan R
    Int J Cancer; 2018 Jan; 142(1):44-56. PubMed ID: 28940326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of an organised programme and social inequalities in mammography screening: A 22-year population-based study in Geneva, Switzerland.
    Sandoval JL; Theler JM; Cullati S; Bouchardy C; Manor O; Gaspoz JM; Guessous I
    Prev Med; 2017 Oct; 103():49-55. PubMed ID: 28778819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organised population-based programmes and change in socioeconomic inequalities in mammography screening: A 1992-2012 nationwide quasi-experimental study.
    Cullati S; von Arx M; Courvoisier DS; Sandoval JL; Manor O; Burton-Jeangros C; Bouchardy C; Guessous I
    Prev Med; 2018 Nov; 116():19-26. PubMed ID: 30145347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer screening programmes and self-reported mammography use in European countries.
    Cardoso R; Hoffmeister M; Brenner H
    Int J Cancer; 2023 Jun; 152(12):2512-2527. PubMed ID: 36883419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening policies and coverage in Europe.
    Anttila A; von Karsa L; Aasmaa A; Fender M; Patnick J; Rebolj M; Nicula F; Vass L; Valerianova Z; Voti L; Sauvaget C; Ronco G
    Eur J Cancer; 2009 Oct; 45(15):2649-58. PubMed ID: 19699081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
    Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
    Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.
    Duport N
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):421-30. PubMed ID: 23146369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries.
    Turnbull E; Priaulx J; van Ravesteyn NT; Heinävaara S; Siljander I; Senore C; Segnan N; Vokó Z; Hagymásy J; Jarm K; Veerus P; de Koning HJ; McKee M
    Health Policy; 2018 Nov; 122(11):1198-1205. PubMed ID: 30195444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening.
    Shapiro S; Coleman EA; Broeders M; Codd M; de Koning H; Fracheboud J; Moss S; Paci E; Stachenko S; Ballard-Barbash R
    Int J Epidemiol; 1998 Oct; 27(5):735-42. PubMed ID: 9839727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France.
    Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Pornet C; Sarlin N; Lunaud P; Desmidt P; Quantin C; Chauvin F; Dancourt V; Arveux P
    Prev Med; 2014 Jun; 63():103-8. PubMed ID: 24345603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union.
    Nicula FA; Anttila A; Neamtiu L; Zakelj MP; Tachezy R; Chil A; Grce M; Kesić V
    Eur J Cancer; 2009 Oct; 45(15):2679-84. PubMed ID: 19699083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
    Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
    Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
    Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
    Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organized screening programmes for breast and cervical cancer in 17 EU countries: trajectories of attendance rates.
    Gianino MM; Lenzi J; Bonaudo M; Fantini MP; Siliquini R; Ricciardi W; Damiani G
    BMC Public Health; 2018 Nov; 18(1):1236. PubMed ID: 30400786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
    Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
    BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment.
    Ballard-Barbash R; Klabunde C; Paci E; Broeders M; Coleman EA; Fracheboud J; Bouchard F; Rennert G; Shapiro S
    Eur J Cancer Prev; 1999 Oct; 8(5):417-26. PubMed ID: 10548397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.
    Vale DB; Anttila A; Ponti A; Senore C; Sankaranaryanan R; Ronco G; Segnan N; Tomatis M; Žakelj MP; Elfström KM; Lönnberg S; Dillner J; Basu P
    Eur J Cancer Prev; 2019 Mar; 28(2):131-140. PubMed ID: 29570103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.